Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.86 |
| ▸ | CA6 | P23280 | 5/20 | 0.86 |
| ▸ | CA7 | P43166 | 5/20 | 0.86 |
| ▸ | CA9 | Q16790 | 5/20 | 0.86 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.86 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.86 |
| ▸ | CA2 | P00918 | 4/20 | 0.86 |
| ▸ | CA4 | P22748 | 4/20 | 0.86 |
| ▸ | CA5A | P35218 | 4/20 | 0.86 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.86 |
| ▸ | CASP2 | P42575 | 2/20 | 0.86 |
| ▸ | F13A1 | P00488 | 2/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.86 |
| ▸ | THPO | P40225 | 2/20 | 0.86 |
| ▸ | MEN1 | O00255 | 2/20 | 0.86 |
| ▸ | RECQL | P46063 | 2/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.86 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.86 |
| ▸ | CA3 | P07451 | 3/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3159043 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL868754 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL869691 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| Thermine SCHEMBL181589 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL869672 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL869496 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL870789 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| SCHEMBL869794 | 1.00 | CA12 (0.86) | CA12CA6CA7CA9CA14 | |
| Thermine SCHEMBL8837088 | 0.96 | CASP2 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9718728 | 0.96 | CASP2 (0.93) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12639248-B2 | Handling node policies in a firmware framework | DELL PRODUCTS L.P. (US) | 2026-05-26 | — | — | US | claimed |
| US-12624503-B2 | Composition for improving softness of tissue and/or towel products | SOLENIS TECHNOLOGIES, L.P. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4731603-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SuSoS AG (CH) | 2026-04-29 | — | — | EP | claimed |
| EP-4018465-B1 | SUPERCAPACITORS COMPRISING PHOSPHONATE AND ARSONATE METAL ORGANIC FRAMEWORKS (MOFS) AS ACTIVE ELECTRODE MATERIALS | UNIV BERLIN TECH (DE) | 2025-12-17 | — | — | EP | claimed |
| CN-120199404-A | Method, system and equipment for constructing automatic auditing rules of clinical immunodetection | 首都医科大学附属北京妇产医院 | 2025-06-24 | — | — | CN | claimed |
| US-12325842-B2 | Decontamination paste consisting of clays and microfibers and method for decontaminating a solid material using said paste | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2025-06-10 | — | — | US | claimed |
| CN-120040780-A | Method for regulating and controlling luminescence of triphenylamine metal-organic framework material based on mixed ligand strategy | 浙江大学 | 2025-05-27 | — | — | CN | claimed |
| EP-4539968-A1 | TREATED MICROPOROUS MEMBRANE | PPG Industries Ohio Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| CN-119355253-B | TPPA reaction unit | 杭州市临安区第一人民医院(杭州市临安区第一人民医院医共体) | 2025-04-11 | — | — | CN | claimed |
| WO-2025070707-A1 | COMPOSITION CONTAINING DIAMINE AND/OR POLYAMINE FOR PREVENTING OR IMPROVING FRAILTY | 東洋紡株式会社 | 2025-04-03 | — | — | WO | claimed |
| EP-1351972-A1 | LIPIDS COMPRISING AN AMINOXY GROUP | Mitsubishi Chemical Corporation (JP) | 2003-10-15 | — | — | EP | claimed |
| WO-2003047549-A2 | POST-COATED LIPOSOME/LIPOPLEX FOR TARGETED DRUG/GENE DELIVERY AND LIPID LINKED TO A DELIVERY, TARGETING OR STABILISING MOIETY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-12 | — | — | WO | claimed |
| US-20020188023-A1 | Compound | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (GB) | 2002-12-12 | — | — | US | claimed |
| WO-2002048170-A1 | LIPIDS COMPRISING AN AMINOXY GROUP | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-06-20 | — | — | WO | claimed |
| WO-2002048380-A2 | GLYCOSILATED CATIONIC LIPIDS FOR LIPOSOMES USED IN DRUG DELIVERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-06-20 | — | — | WO | claimed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0918790-A1 | POLYCATIONIC STEROL DERIVATIVES AS TRANSFECTION AGENTS | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE (GB) | 1999-06-02 | — | — | EP | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| WO-1997045442-A1 | POLYCATIONIC STEROL DERIVATIVES AS TRANSFECTION AGENTS | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (GB) | 1997-12-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12639248-B2 | Handling node policies in a firmware framework | INTS6, INTS9, ILK | CA12 922/4885CA6 2562/4885CA7 3815/4885 |
| US-12624503-B2 | Composition for improving softness of tissue and/or towel products | CUTA, TTPA, PHOSPHO1 | CA12 2023/4885CA6 904/4885CA7 1941/4885 |
| US-20020188023-A1 | Compound | CYP46A1, CYP11B2, NR1H3 | CA12 654/4885CA6 873/4885CA7 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.